Sickle Cell Disease
Conditions
Interventions
This is a two-arm, randomized, controlled clinical trial with no masking. The experimental group and the control group each consist of 20 children. Randomization of participants is performed by drawin
Sponsors
Núcleo de Pesquisa em Oncologia
Centro de Hemoterapia e Hematologia do Pará
Eligibility
Age
6 Years to 13 Years
Inclusion criteria
Inclusion criteria: Children of both sexes; with a confirmed diagnosis of Sickle Cell Disease - SCD through hemoglobin electrophoresis; aged between 6 years and 13 years 11 months and 29 days; who assent and whose legal representatives freely consent to participation after being fully informed about the project
Exclusion criteria
Exclusion criteria: Children with associated diseases that affect the lungs and may cause bias in the results, such as cystic fibrosis or systemic sclerosis; children and adolescents with severe neurological sequelae that make it impossible to perform the proposed exercises
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find improvement or less decline in lung function and functional capacity in children who performed breathing exercises | — |
Primary
| Measure | Time frame |
|---|---|
| It is expected to find less cognitive decline over two years in children with sickle cell disease who performed breathing exercises compared to children in the control group | — |
Countries
Brazil
Contacts
Public ContactRoberta de Melo
Centro de Hemoterapia e Hematologia do Pará
Outcome results
None listed